Venture Capital

Enhanced Games: 1789 Capital Co-Leads Series B Funding Round

By Amit Chowdhry ● Feb 13, 2025

Omeed Malik, Chris Buskirk, and Donald Trump Jr.'s 1789 Capital announced it co-led a multi-million-dollar Series B round for the Enhanced Games, along with significant contributions from Karatage, Christian Angermayer's Apeiron Investment Group, and other blue chip investors. This new funding round will drive the Enhanced Games towards hosting its upcoming inaugural record-breaking event.

Newronika: €13.6 Million (Series B) Closed For Advanced Deep Brain Stimulation Platform

By Amit Chowdhry ● Feb 13, 2025

Newronika, a leader in advanced deep brain stimulation, announced the closing of its €13.6 million Series B funding round. This funding was led by new investor Fondazione ENEA Tech e Biomedical, with additional participation from existing investors Indaco Venture Partners SGR, Innogest SGR, Wille Finance, TNBT Capital, and F3F.

EnCharge AI: $100 Million (Series B) Raised For Developing Analog In-Memory-Computing AI Chips

By Amit Chowdhry ● Feb 13, 2025

EnCharge AI, a company developing first-of-its-kind analog in-memory-computing AI chips, announced it has raised over $100 million in Series B funding. Tiger Global led this round and the new financial investors included Maverick Silicon, Capital TEN, SIP Global Partners, Zero Infinity Partners, CTBC VC, Vanderbilt University, Morgan Creek Digital, and others. Previous investors participating in the Series B round include RTX Ventures, Anzu Partners, Scout Ventures, AlleyCorp, ACVC, and S5V.

Cambridge Savings Bank: $20 Million Line Of Credit Offered To Arctaris Impact Investors

By Amit Chowdhry ● Feb 13, 2025

Cambridge Savings Bank (CSB), a full-service mutual bank with $7 billion in assets, announced that its Asset-Based Lending (ABL) team has provided a $20 million revolving line of credit to Arctaris Impact Investors. Based in Wellesley, Massachusetts, Arctaris will utilize the financing to expand its support for profitable, high-growth businesses in underserved communities across the U.S.

Helicore Biopharma: $65 Million (Series A) Raised For Glucose-Dependent Insulinotropic Peptide Platform

By Amit Chowdhry ● Feb 13, 2025

Helicore Biopharma, a biopharmaceutical company focused on discovering and developing first-in-class glucose-dependent insulinotropic peptide (GIP) antagonists for obesity and related conditions, announced its emergence from stealth mode with $65 million in Series A financing. This funding round was co-led by founding investor Versant Ventures and by OrbiMed, with participation from Longitude Capital and Wellington Management.

Colesco Capital: Over €800 Million Raised And Adam Willmott Named As Co-Head of Origination

By Amit Chowdhry ● Feb 13, 2025

Colesco, a sustainability-led direct lender with a mission to unite capital and purpose, announced it raised more than €800 million in its first platform close, welcoming APG and Rabobank as cornerstone investors. The firm also announced it has appointed Adam Willmott as Co-Head of Origination in its London office.